The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages

Arora, Prerna, Zhang, Lu, Nehlmeier, Inga, Kempf, Amy, Cossmann, Anne, Dopfer-Jablonka, Alexandra, Schulz, Sebastian R.; Jäck, Hans-Martin, Behrens, Georg M. N.; Pöhlmann, Stefan, Hoffmann, Markus

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages

Arora, Prerna, Zhang, Lu, Nehlmeier, Inga, Kempf, Amy, Cossmann, Anne, Dopfer-Jablonka, Alexandra, Schulz, Sebastian R.; Jäck, Hans-Martin, Behrens, Georg M. N.; Pöhlmann, Stefan, Hoffmann, Markus.

The Lancet. Infectious diseases ; 2022.

Article in English | EuropePMC | ID: covidwho-2092206

Search on Google

Print

XML

Collection: Databases of international organizations Database: EuropePMC Type of study: Experimental Studies Topics: Vaccines Language: English Journal: The Lancet. Infectious diseases Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Print

XML

Collection: Databases of international organizations Database: EuropePMC Type of study: Experimental Studies Topics: Vaccines Language: English Journal: The Lancet. Infectious diseases Year: 2022 Document Type: Article